Dr. Rachel Greenberg
Claim this profileMore about Rachel Greenberg
Clinical Trial Related
1 year of experience running clinical trials · Led 1 trial as a Principal Investigator · 0 Active Clinical Trials
Treatments Rachel Greenberg has experience with
- Guanfacine Hydrochloride Immediate Release
Breakdown of trials Rachel Greenberg has run
Fallopian Tube Spasm
Impulsivity in Children
Attention Deficit Hyperactivity Disorder (ADHD)
Hyperactivity in Children
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Rachel Greenberg specialize in?
Rachel Greenberg focuses on Fallopian Tube Spasm and Impulsivity in Children. In particular, much of their work with Fallopian Tube Spasm has involved treating patients, or patients who are undergoing treatment.
Is Rachel Greenberg currently recruiting for clinical trials?
No, Rachel Greenberg is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Rachel Greenberg has studied deeply?
Yes, Rachel Greenberg has studied treatments such as Guanfacine Hydrochloride Immediate Release.
What is the best way to schedule an appointment with Rachel Greenberg?
Apply for one of the trials that Rachel Greenberg is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.